INNOventure
VC Fund
Kraków, Poland
INNOventure is a VC fund in Kraków focused on Health Care and Artificial Intelligence. INNOventure helps scientists, inventors and entrepreneurs develop business projects based on the results of research and development.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries INNOventure invests in
Stages INNOventure invests in
Countries INNOventure invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $263k–$847k
- Pre-Seed
- $250k–$305k
Investment Focus
Industry
- Health Care 5 (28%)
- Artificial Intelligence 5 (28%)
- Medical 4 (22%)
- Software 4 (22%)
- Biotechnology 3 (17%)
Stage
- Seed 14 (78%)
- Pre-Seed 4 (22%)
Country
- Poland 17 (94%)
- United States 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Marcin Bielówka
Founder & Chief Executive Officer
|
Founder & Chief Executive Officer | Total investments: 9 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Digital First AI offers a platform that enables users to create and execute marketing strategies quickly using AI-generated content and tactics. The service includes a library of proven marketing tactics, funnel management tools, and collaboration features for teams. It aims to simplify the marketing process for businesses of all sizes, helpingthem optimize their campaigns efficiently. | $250K / Pre-Seed / Feb 14, 2022 | ||
| Phonemic is a company that offers RTL design and verification services for FPGA and ASIC development. The company's team of engineers provides solutions for digital signal processing, cryptography, system-level design, and integration. Phonemic also develops and deploys its own proprietary IP-Cores for clients' designs. | Seed / Jan 28, 2022 | ||
| OpenApp is a payment platform that provides assistance with payment systems and ensures security by using biometric technology. | Seed / Sep 23, 2021 | ||
| Laven helps employers offer complementary health insurance for their employees. | Seed / Sep 01, 2021 | ||
| Saventic Health is a med-tech company that develops an AI-powered clinical decision support system to support diagnosing rare diseases. | Seed / Dec 01, 2020 | ||
| We are a B2B Marketplace offering full support in printing services for companies around Europe.We deliver high quality print products containing all available print technologies on the market plus creative and product design, print process management with quality staging and logistic for the best Customer Success. We are all-in-one solution forany company, delivering time and cost savings, keeping the high quality production. It's simple, professional, it's easy... just prints me! | $266.1K / Pre-Seed / Nov 26, 2020 | ||
| Neuromedical is a medical device company that supplies electro-stimulating equipment for clinical and therapeutic use. The company provides devices designed to support treatments involving nerve stimulation and pain management. Its products are used by healthcare professionals in various medical settings. Neuromedical focuses on deliveringequipment that meets clinical standards for safety and effectiveness. The company works with institutions and practitioners to support patient care through specialized technology. Its offerings are applications in neuromodulation and rehabilitation. | Seed / May 17, 2020 | ||
| RevDebug is the result of over 20 years of experience creating enterprise level software for large companies. RevDeBug records the entire internal state of a program and enables developers to go back in time to track and fix the root cause of bugs. No such solution has ever existed for Microsoft.NET platform: RevDebug is a true game-changer in theprocess of eliminating bugs, as it turns the current approach completely upside down. It has never been so easy. In fact, for certain bugs it hasn’t even been possible at all. Now it is. RevDebug makes fixing bugs faster. | $475.7K / Seed / May 08, 2020 | ||
| Amorphis Pharma Development specializes in the amorphization and stabilization of pharmaceutical active substances to create drugs. | Seed / Dec 05, 2019 | ||
| Cardiomatics offers cutting-edge, cloud AI-based digital analysis of ECG data. It is a medical-grade system, based on accurate algorithms, ensuring high-quality and trusted outcomes. As a digital health technology developer, Cardiomatics cooperates with physicians, manufacturers, and providers of ECG devices globally. | $304.6K / Pre-Seed / Jul 12, 2019 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does INNOventure invest in?
INNOventure invests primarily in Health Care, Artificial Intelligence and Medical startups, most often at Seed and Pre-Seed stage. Most of the 18 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does INNOventure invest in?
INNOventure typically joins rounds of $263k–$847k at Seed and $250k–$305k at Pre-Seed. These are whole funding-round sizes, not INNOventure's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds INNOventure took part in.
How do I contact INNOventure?
Public channels for INNOventure include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at INNOventure?
The team at INNOventure includes Marcin Bielówka (Founder & Chief Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
